Core Points - YXTT Pharmaceutical Group Co., Ltd. has proposed amendments to its Articles of Association, which will be submitted for shareholder approval [1][3][43] - The amendments are based on relevant laws and regulations, including the Company Law of the People's Republic of China and the Shenzhen Stock Exchange Listing Rules [1][3] - The company will hold its third extraordinary general meeting of 2025 on November 13, 2025, to discuss the proposed amendments and other matters [7][8][38] Summary of Amendments - The specific changes to the Articles of Association have been outlined in a comparison table, with other provisions remaining unchanged [2] - The amendments will be subject to final approval by the relevant administrative authorities [3] Meeting Details - The extraordinary general meeting will be held on November 13, 2025, at 14:00, with both on-site and online voting options available [7][8][9] - Shareholders must register to attend the meeting, with the registration deadline set for November 12, 2025 [17][18][19] - Voting will be conducted using a cumulative voting system for certain proposals, requiring a two-thirds majority for special resolutions and a simple majority for ordinary resolutions [15][16][38] Board of Directors Election - The company will elect its seventh board of directors, consisting of nine members, including five non-independent directors and three independent directors [67][68] - The candidates for the non-independent and independent director positions have been nominated and will be presented for shareholder voting [67][68][39][40]
一心堂药业集团股份有限公司 关于修订《公司章程》的公告